Poging GOUD - Vrij
Bayer’s Stroke-Prevention Drug Shows Positive Results at Trial
The Wall Street Journal
|November 25, 2025
Shares in Bayer rose after the company reported positive results from a clinical trial for an experimental stroke-preventing drug that had previously been shown to be ineffective in another trial.
Bayer's pharmaceutical business has been hit by pressure from drugs going off patent.
Dit verhaal komt uit de November 25, 2025-editie van The Wall Street Journal.
Abonneer u op Magzter GOLD voor toegang tot duizenden zorgvuldig samengestelde premiumverhalen en meer dan 9000 tijdschriften en kranten.
Bent u al abonnee? Aanmelden
Listen
Translate
-
+
Change font size

